Cargando…
Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy
Inflammatory polyradiculoneuropathy (IMPN) is one of the causes of sudden onset of neuromuscular signs such as para-/tetraparesis in young cats. Even though most cases have a favorable outcome, persistent deficits, relapses, and progressive courses are occasionally seen. As clinical presentation doe...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263917/ https://www.ncbi.nlm.nih.gov/pubmed/35812863 http://dx.doi.org/10.3389/fvets.2022.928309 |
_version_ | 1784742855926874112 |
---|---|
author | Kolb, Ninja Matiasek, Kaspar van Renen, Jana Fischer, Andrea Zablotski, Yury Wieländer, Franziska Nessler, Jasmin Tipold, Andrea Cappello, Rodolfo Flegel, Thomas Loderstedt, Shenja Dietzel, Josephine Gnirs, Kirsten Rentmeister, Kai Rupp, Stephan von Klopmann, Thilo Steffen, Frank Jurina, Konrad Del Vecchio, Omar V. Deutschland, Martin König, Florian Gandini, Gualtiero Harcourt-Brown, Tom Kornberg, Marion Bianchi, Ezio Gagliardo, Teresa Menchetti, Marika Schenk, Henning Tabanez, Joana Rosati, Marco |
author_facet | Kolb, Ninja Matiasek, Kaspar van Renen, Jana Fischer, Andrea Zablotski, Yury Wieländer, Franziska Nessler, Jasmin Tipold, Andrea Cappello, Rodolfo Flegel, Thomas Loderstedt, Shenja Dietzel, Josephine Gnirs, Kirsten Rentmeister, Kai Rupp, Stephan von Klopmann, Thilo Steffen, Frank Jurina, Konrad Del Vecchio, Omar V. Deutschland, Martin König, Florian Gandini, Gualtiero Harcourt-Brown, Tom Kornberg, Marion Bianchi, Ezio Gagliardo, Teresa Menchetti, Marika Schenk, Henning Tabanez, Joana Rosati, Marco |
author_sort | Kolb, Ninja |
collection | PubMed |
description | Inflammatory polyradiculoneuropathy (IMPN) is one of the causes of sudden onset of neuromuscular signs such as para-/tetraparesis in young cats. Even though most cases have a favorable outcome, persistent deficits, relapses, and progressive courses are occasionally seen. As clinical presentation does not always appear to predict outcome and risk of recurrence, this study was initiated to screen for prognostic biopsy findings in a large cohort of histologically confirmed IMPN cases with clinical follow-up. In total, nerve and muscle specimens of 107 cats with biopsy diagnosis of presumed autoreactive inflammatory polyneuropathy and 22 control cases were reviewed by two blinded raters for a set of 36 histological parameters. To identify patterns and subtypes of IMPN, hierarchical k-means clustering of 33 histologic variables was performed. Then, the impact of histological parameters on IMPN outcome was evaluated via an univariate analysis to identify variables for the final multivariate model. The data on immediate outcome and follow-up were collected from submitting neurologists using a purpose-designed questionnaire. Hierarchical k-means clustering sorted the tissues into 4 main categories: cluster 1 (44/129) represents a purely inflammatory IMPN picture, whereas cluster 2 (47/129) was accompanied by demyelinating features and cluster 3 (16/129) by Wallerian degeneration. Cluster 4 (22/129) reflects normal tissues from non-neuropathic control cats. Returned questionnaires provided detailed information on outcome in 63 animals. They were categorized into recovered and non-recovered. Thereby, fiber-invasive infiltrates by mononuclear cells and mild fiber loss in intramuscular nerve branches correlated with higher probabilities of recovery. Remyelination in semithin sections, on the other hand, is correlated with a less favorable outcome. Animals grouping in cluster 1 had a tendency to a higher probability of recovery compared to other clusters. In conclusion, diagnosis of feline IMPN from nerve and muscle biopsies allowed for the identification of histologic features that were positively or negatively correlated with outcome. |
format | Online Article Text |
id | pubmed-9263917 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92639172022-07-09 Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy Kolb, Ninja Matiasek, Kaspar van Renen, Jana Fischer, Andrea Zablotski, Yury Wieländer, Franziska Nessler, Jasmin Tipold, Andrea Cappello, Rodolfo Flegel, Thomas Loderstedt, Shenja Dietzel, Josephine Gnirs, Kirsten Rentmeister, Kai Rupp, Stephan von Klopmann, Thilo Steffen, Frank Jurina, Konrad Del Vecchio, Omar V. Deutschland, Martin König, Florian Gandini, Gualtiero Harcourt-Brown, Tom Kornberg, Marion Bianchi, Ezio Gagliardo, Teresa Menchetti, Marika Schenk, Henning Tabanez, Joana Rosati, Marco Front Vet Sci Veterinary Science Inflammatory polyradiculoneuropathy (IMPN) is one of the causes of sudden onset of neuromuscular signs such as para-/tetraparesis in young cats. Even though most cases have a favorable outcome, persistent deficits, relapses, and progressive courses are occasionally seen. As clinical presentation does not always appear to predict outcome and risk of recurrence, this study was initiated to screen for prognostic biopsy findings in a large cohort of histologically confirmed IMPN cases with clinical follow-up. In total, nerve and muscle specimens of 107 cats with biopsy diagnosis of presumed autoreactive inflammatory polyneuropathy and 22 control cases were reviewed by two blinded raters for a set of 36 histological parameters. To identify patterns and subtypes of IMPN, hierarchical k-means clustering of 33 histologic variables was performed. Then, the impact of histological parameters on IMPN outcome was evaluated via an univariate analysis to identify variables for the final multivariate model. The data on immediate outcome and follow-up were collected from submitting neurologists using a purpose-designed questionnaire. Hierarchical k-means clustering sorted the tissues into 4 main categories: cluster 1 (44/129) represents a purely inflammatory IMPN picture, whereas cluster 2 (47/129) was accompanied by demyelinating features and cluster 3 (16/129) by Wallerian degeneration. Cluster 4 (22/129) reflects normal tissues from non-neuropathic control cats. Returned questionnaires provided detailed information on outcome in 63 animals. They were categorized into recovered and non-recovered. Thereby, fiber-invasive infiltrates by mononuclear cells and mild fiber loss in intramuscular nerve branches correlated with higher probabilities of recovery. Remyelination in semithin sections, on the other hand, is correlated with a less favorable outcome. Animals grouping in cluster 1 had a tendency to a higher probability of recovery compared to other clusters. In conclusion, diagnosis of feline IMPN from nerve and muscle biopsies allowed for the identification of histologic features that were positively or negatively correlated with outcome. Frontiers Media S.A. 2022-06-24 /pmc/articles/PMC9263917/ /pubmed/35812863 http://dx.doi.org/10.3389/fvets.2022.928309 Text en Copyright © 2022 Kolb, Matiasek, van Renen, Fischer, Zablotski, Wieländer, Nessler, Tipold, Cappello, Flegel, Loderstedt, Dietzel, Gnirs, Rentmeister, Rupp, von Klopmann, Steffen, Jurina, Del Vecchio, Deutschland, König, Gandini, Harcourt-Brown, Kornberg, Bianchi, Gagliardo, Menchetti, Schenk, Tabanez and Rosati. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Veterinary Science Kolb, Ninja Matiasek, Kaspar van Renen, Jana Fischer, Andrea Zablotski, Yury Wieländer, Franziska Nessler, Jasmin Tipold, Andrea Cappello, Rodolfo Flegel, Thomas Loderstedt, Shenja Dietzel, Josephine Gnirs, Kirsten Rentmeister, Kai Rupp, Stephan von Klopmann, Thilo Steffen, Frank Jurina, Konrad Del Vecchio, Omar V. Deutschland, Martin König, Florian Gandini, Gualtiero Harcourt-Brown, Tom Kornberg, Marion Bianchi, Ezio Gagliardo, Teresa Menchetti, Marika Schenk, Henning Tabanez, Joana Rosati, Marco Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title | Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title_full | Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title_fullStr | Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title_full_unstemmed | Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title_short | Biopsy Characteristics, Subtypes, and Prognostic Features in 107 Cases of Feline Presumed Immune-Mediated Polyneuropathy |
title_sort | biopsy characteristics, subtypes, and prognostic features in 107 cases of feline presumed immune-mediated polyneuropathy |
topic | Veterinary Science |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263917/ https://www.ncbi.nlm.nih.gov/pubmed/35812863 http://dx.doi.org/10.3389/fvets.2022.928309 |
work_keys_str_mv | AT kolbninja biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT matiasekkaspar biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT vanrenenjana biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT fischerandrea biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT zablotskiyury biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT wielanderfranziska biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT nesslerjasmin biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT tipoldandrea biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT cappellorodolfo biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT flegelthomas biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT loderstedtshenja biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT dietzeljosephine biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT gnirskirsten biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT rentmeisterkai biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT ruppstephan biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT vonklopmannthilo biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT steffenfrank biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT jurinakonrad biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT delvecchioomarv biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT deutschlandmartin biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT konigflorian biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT gandinigualtiero biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT harcourtbrowntom biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT kornbergmarion biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT bianchiezio biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT gagliardoteresa biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT menchettimarika biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT schenkhenning biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT tabanezjoana biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy AT rosatimarco biopsycharacteristicssubtypesandprognosticfeaturesin107casesoffelinepresumedimmunemediatedpolyneuropathy |